Enfermedades Sistémicas de Base Autoinmune

Molina-Collada J; Jiménez-Núñez FG; Ortiz-Márquez F; Rodríguez-Merlos P; Mayordomo L; Azabal-Perez C; Berrocal-Acedo M; Uson J; Garmendia E; Arostegui-Lavilla J; García-Vivar ML; Exposito-Molinero MR; Medina-Luezas J; Corral Bote A; Robustillo-Villarino M; Zúñiga-Vera A; Collado P; Alcalde-Villar M; Olivas-Vergara O; Estrada P; Navarro-Ángeles V; Blanco-Cáceres B; Ferre-Sanfrancisco M; Corrales-Martinez A; Corrales-Selaya C; Coronel L; de Agustin de Oro JJ; Miguelez-Sanchez JR; Peiteado D; Monjo-Henry I; Villalba A; Plasencia-Rodríguez C; Novella-Navarro M; Moragues C; Valencia Muntala L; Vicente-Rabaneda EF; Castañeda S; Bellón-Cano JM; Naredo E.

Gender influence on ultrasound-assessed therapeutic response in rheumatoid arthritis: Insights from the GENder on UltraSound (GENUS) study.

SEMINARS IN ARTHRITIS AND RHEUMATISM. 2026; 79: 152993-152993 [doi:10.1016/j.semarthrit.2026.152993]

Plasencia-Rodríguez, C; Ortiz, AM; Carmona, L; Guerra-Rodríguez, M; del Campo, PD; Alvaro-Gracia, JM.

Choosing the next option: a scenario-based roadmap for b/tsDMARD sequencing in rheumatoid arthritis

CLINICAL RHEUMATOLOGY. 2026; : [doi:10.1007/s10067-026-08172-1]

Ahmadzay, ZF; Ornbjerg, LM; Ostergaard, M; Jensen, KY; Jorgensen, JB; Heberg, J; Loft, AG; Michelsen, B; Jones, GT; Hellamand, P; Moller-Bisgaard, S; Kazemi, MS; Reikandeh, PK; Závada, J; Horák, P; Bernardes, M; Vieira-Sousa, E; Castrejón, I; Otero-Varela, L; Codreanu, C; Kuusalo, L; Rantalaiho, V; Regierer, AC; Reich, A; Möller, B; Micheroli, R; Mielnik, P; Provan, SA; Lass, K; Vorobjov, S; Rotar, Z; Pirkmajer, KP; Iannone, F; Conti, F; Gudbjornsson, B; Di Giuseppe, D; van de Sande, M; Macfarlane, GJ; Yarkan-Tugsal, H; Glintborg, B; Hetland, ML.

Impact of cardiometabolic comorbidities on clinical characteristics, prescription patterns and retention rate of first b/tsDMARD treatment in 5299 European real-world patients with psoriatic arthritis

RMD Open. 2026; 12(2): [doi:10.1136/rmdopen-2025-006477]

Tarantola, L; Rebollo-Giménez, AI; Sciutto, A; Naddei, R; Varnier, GC; Pilkington, C; Maillard, S; Civino, A; Tsitsami, E; de Inocencio, J; Jelusic, M; Vojinovic, J; Espada, G; Makay, B; Katsicas, MM; Pratsidou-Gertsi, P; Lazarevic, D; Rao, AP; Consolaro, A; Pistorio, A; Ravelli, A; Rosina, S.

Introducing a parent-centred composite disease activity score for remote monitoring in juvenile dermatomyositis

RHEUMATOLOGY. 2026; 65(5): [doi:10.1093/rheumatology/keag192]

Molina-Collada, J; Bellón, JM; Blanco-Cáceres, B; Coronel, L; de Agustín, JJ; Estrada, P; Sánchez, EG; Vivar, MLG; Olivas-Vergara, O; Núñez, FGJ; Mayordomo, L; Moragues, C; Rebollo-Giménez, AI; Uson, J; Vicente-Rabaneda, EF; Naredo, E.

Ultrasound evaluation of muscle quality in rheumatoid arthritis: a reliability study of the Spanish Ultrasound Muscle Assessment in Rheumatoid Arthritis (SpUMAR) score

ARTHRITIS RESEARCH & THERAPY. 2026; 28(1): [doi:10.1186/s13075-026-03815-9]

Zazzetti, F; Orillion, A; Sbarigia, U; Sheahan, A; Blacketer, C; van Speybroeck, M; Gasman, S; Sönmez, R; Noss, EH; Ugarte-Gil, MF; Gamboa-Cardenas, RV; Pimentel-Quiroz, V; Pons-Estel, GJ; Quintana, R; Saurit, V; Pisoni, CN; Monticielo, OA; Ribeiro, FM; Esquivel-Valerio, JA; Núñez-Alvarez, CA; Zuñiga, K; Rebella, M; Michaud, K; Katz, P; Kandane-Rathnayake, R; Morand, EF; Louthrenoo, W; Hoi, A; Nikpour, M; Navarra, S; Lau, CS; Luo, SF; Hamijoyo, L; Li, ZG; Pego-Reigosa, JM; Rúa-Figueroa, I; Plaza, Z; Izquierdo, MG; Martínez-Barrio, J; Alén, JC; Fernández-Nebro, A; Menor-Almagro, R; Tomero, E; García, FJN.

Demographic and clinical characteristics of patients with systemic lupus erythematosus across five registries: the LupusNet federated data network

Lupus Science & Medicine. 2026; 13(1): [doi:10.1136/lupus-2025-001881]

Tomelleri, A; Reider, SJ; Dejaco, C; Schmidt, WA; Ponte, C; Hocevar, A; Agueda, AF; Alibaz-Oner, F; Appenzeller, S; Aschwanden, M; Bastian, H; Bosch, P; Camellino, D; Casteleyn, V; Chrysidis, S; Daikeler, T; De Miguel, E; Diamantopoulos, AP; Filippou, G; Goel, R; Hanova, P; Hartung, W; Ikeda, K; Inanc, N; Jousse-Joulin, S; Juche, A; Karalilova, R; Keller, KK; Kjær, SG; Kohler, MJ; Koster, MJ; Macchioni, P; Mackie, SL; Milchert, M; Misra, DP; Molina-Collada, J; Monti, S; Nakagomi, D; Naredo, E; Nielsen, BD; Ogasawara, M; Roth, J; Schäfer, VS; Seitz, L; Seitz, P; Shumnalieva, R; Terslev, L; van der Geest, KSM; Vreju, FA; D'Agostino, MA; Keen, HI; Mandl, P; Pineda, C; Duftner, C; Bond, M.

Definitions and online reliability assessment of elementary ultrasound lesions in Takayasu arteritis: a study from the OMERACT Ultrasound Working Group

SEMINARS IN ARTHRITIS AND RHEUMATISM. 2026; 77: Nº de citas: 1 [doi:10.1016/j.semarthrit.2026.152927]

Ríos, I; Schiaffino, MT; López-Navarro, B; Triguero-Martínez, A; Lin, MRY; Torres-Torresano, M; Struys, EA; Alvarez, S; Román, M; Abad-Santos, F; Castañeda, S; Garcia-Castañeda, N; de Jonge, R; Jansen, G; Castrejón, I; González-Alvaro, I; Puig-Kröger, A.

Monocytes from inflammatory arthritis patients accumulate methotrexate and their transcriptome predicts methotrexate clinical response

CELLULAR AND MOLECULAR LIFE SCIENCES. 2026; 83(1): [doi:10.1007/s00018-026-06162-9]

Loricera, J; Molina-Collada, J; Nieto, JC; Sánchez-Lucas, M; Silva-Díaz, MT; Moya, P; Labrador, E; Ferraz-Amaro, I; Blanco, R.

Switching from Originator Tocilizumab to Biosimilar in Giant Cell Arteritis: Evaluation of Effectiveness and Safety in a Multicenter Cohort of 38 Patients

DRUGS & AGING. 2026; 43(3): 277-284 Nº de citas: 1 [doi:10.1007/s40266-026-01281-1]

Monjo-Henry, I; Fernández-Fernández, E; Miranda-Carus, ME; Nieto-Carvalhal, B; Ortíz, GT; Molina-Collada, J; De Miguel, E.

Dynamic vascular changes on long-term ultrasound monitoring predict relapse in large-vessel giant cell arteritis

ARTHRITIS RESEARCH & THERAPY. 2026; 28(1): [doi:10.1186/s13075-026-03759-0]

Rebollo-Giménez, AI; Rosina, S; Ridella, F; Orsi, SM; Aldera, E; Burrone, M; Natoli, V; Consolaro, A; Bovis, F; Naredo, E; Ravelli, A.

Discordance between non-zero physician's global scores and absence of active joints in juvenile idiopathic arthritis: multicenter vs. single-center cohorts

Frontiers in Pediatrics. 2026; 14: [doi:10.3389/fped.2026.1702667]

Macmahon, JM; Ravelli, A; Rebollo-Giménez, AI; Natoli, V; Campone, C; Bovis, F; Nozawa, T; Goh, YI; Consolaro, A; Feldman, BM; Rosina, S.

Toward a Treat-to-Target Strategy in Juvenile Dermatomyositis: What Are the Suitable Targets and Optimal Timing of Their Achievement?

Arthritis & Rheumatology. 2026; 78(4): [doi:10.1002/art.43431]

Vidal-Montal, P; Fabregat, A; Altabás-González, I; Pego-Reigosa, JM; Hernández-Martínez, A; Rua-Figueroa, I; Salman-Monte, T; Moriano, C; Segura, BT; Vela, P; Pareja-Martínez, A; García-Cirera, S; García-Villanueva, MJ; Garrote-Corral, S; Heredia, S; Riancho-Zarrabeitia, L; Manrique-Arija, S; Bernárdez, J; Magallares, B; Torrente-Segarra, V; Frade-Sosa, B; Gómez-Puerta, JA; Martinez-Barrio, J; Narvaez, J.

Real-world experience with belimumab-based triple therapy in proliferative lupus nephritis: data from the BEL-SPAIN Registry

Lupus Science & Medicine. 2026; 13(1): [doi:10.1136/lupus-2025-001825]

Rua-Figueroa, I; Martínez-Barrio, J; Plaza, Z; Jiménez, N; Galindo-Izquierdo, M; Uriarte, E; Fernandez-Nebro, A; Alen, JC; Rosas, J; Narváez, J; Aurrecoechea, E; Freire, M; Tomero, E; Sanguesa, C; Iniguez, C; Perez, A; Garrote, S; Lozano-Rivas, N; Ibarguengoitia, O; Salgado, E; Erausquin, C; Monte, TCS; Menor, R; Altabás-González, I; Gil, JF; Nolla, JM; Pego-Reigosa, JM.

Self-reported depression on the Lupus Impact Tracker questionnaire (LIT) is associated with glucocorticoid use and fibromyalgia in systemic lupus erythematosus, according to RELESSER-PROS registry data

BMC Rheumatology. 2026; 10(1): [doi:10.1186/s41927-025-00612-w]

Molina-Collada, J; Ponte, C; Schäfer, VS; de Miguel, E.

Imaging-guided stratification in giant cell arteritis: prognostic and therapeutic implications

Therapeutic Advances in Musculoskeletal Disease. 2026; 18: [doi:10.1177/1759720X251414122]

Retuerto-Guerrero, M; Morales, CM; Pareja-Martínez, A; Molina-Esteban, N; Puig-Buendia, J; Llorente, CP; Cofiño, ALC; Martínez-Barrio, J; Vidal-Montal, P; Cudos, ES; Cabrera, LM; Arribas, GG; Alén, JC; de Aberasturi, JRDJ; Madrigal, JMB; Corral, JB; Oliva, AC; Casasempere, PV; Gonzalez, MC; Manteca, MCF; Capusan, TM; Calvo, CO; Rodríguez, DR; Herrero, AS; Ortega-Valín, L; Alvarez, ED.

Real-world experience of anifrolumab in 30 patients with refractory DM: a multicentre-multidisciplinary retrospective study

RHEUMATOLOGY. 2025; 65(2): [doi:10.1093/rheumatology/keaf662]

Altabás-González, I; Rua-Figueroa, I; Roberts, K; Mamani, IL; Mouriño, C; Martinez-Barrio, J; Izquierdo, MG; Calvo-Alén, J; Erausquin, C; Serrano-Benavente, B; Uriarte, E; Tomero, E; Freire-González, M; Blanco, R; Salgado, E; Gomez-Sabater, S; Fernandez-Nebro, A; Sangüesa, C; Narvaez, J; Vázquez, NM; Menor-Almagro, R; de Salazar, JCRG; Aurrecoechea, E; Ibarguengoitia-Barrena, O; Montilla, C; Bonilla, G; Segarra, VT; Juan-Mas, A; García-Villanueva, MJ; Morales, CM; Horcada, L; Lozano-Rivas, N; Iñiguez, C; Arevalo, M; Paredes, B; Exposito, L; Toyos, FJ; Flores-Fernandez, E; Medina, JN; Gil, JJF; Bohorquez, C; Pego-Reigosa, JM.

Validation of proposals for definitions of moderate and severe disease activity in SLE: impact on flares, quality of life, damage accrual, hospitalisations and mortality

Lupus Science & Medicine. 2025; 12(2): [doi:10.1136/lupus-2025-001766]

Martín-Gutiérrez A; Loricera J; Prieto-Peña D; Aldasoro V; Maiz O; de Miguel E; Galíndez-Agirregoikoa E; Ferraz-Amaro I; Castañeda S; Blanco R.

Tocilizumab monotherapy versus combined in aortitis associated with giant cell arteritis: Factors associated with imaging remission in a multicenter open-label study of 196 patients.

SEMINARS IN ARTHRITIS AND RHEUMATISM. 2025; 75: 152869-152869 Nº de citas: 1 [doi:10.1016/j.semarthrit.2025.152869]